HEADER ANTIMICROBIAL PROTEIN 05-MAR-08 2K1I TITLE SYNTHESIS, STRUCTURE AND ACTIVITIES OF AN ORAL MUCOSAL ALPHA-DEFENSIN TITLE 2 FROM RHESUS MACAQUE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MUCOSAL ALPHA-DEFENSIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS ANTIMICROBIAL PEPTIDE, RHESUS MACAQUE, DEFENSIN, ANTI PARALLEL BETA KEYWDS 2 SHEET, ANTIMICROBIAL PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR S.V.VASUDEVAN,J.YUAN,G.OSAPAY,P.TRAN,K.TAI,M.SELSTED,M.J.COCCO REVDAT 4 24-JAN-18 2K1I 1 AUTHOR REVDAT 3 19-JUN-13 2K1I 1 JRNL VERSN REVDAT 2 24-FEB-09 2K1I 1 VERSN REVDAT 1 28-OCT-08 2K1I 0 JRNL AUTH S.VASUDEVAN,J.YUAN,G.OSAPAY,P.TRAN,K.TAI,W.LIANG,V.KUMAR, JRNL AUTH 2 M.E.SELSTED,M.J.COCCO JRNL TITL SYNTHESIS, STRUCTURE, AND ACTIVITIES OF AN ORAL MUCOSAL JRNL TITL 2 ALPHA-DEFENSIN FROM RHESUS MACAQUE. JRNL REF J.BIOL.CHEM. V. 283 35869 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18930922 JRNL DOI 10.1074/JBC.M806915200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NMRDRAW 2.2, X-PLOR NIH 2.18 REMARK 3 AUTHORS : DELAGLIO, GRZESIEK, VUISTER, ZHU, PFEIFER AND BAX REMARK 3 (NMRDRAW), SCHWIETERS, KUSZEWSKI, TJANDRA AND REMARK 3 CLORE (X-PLOR NIH) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2K1I COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1000100557. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 303 REMARK 210 PH : 3.8 REMARK 210 IONIC STRENGTH : 0.05 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1MG/ML ROAD-1, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H TOCSY; 2D DQF-COSY; 2D REMARK 210 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 60 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS, STRUTURES REMARK 210 WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THE STRUCTURE OF THE POLYPEPTIDE WAS DETERMINED USING REMARK 210 DISTANCE AND DIHEDRAL CONSTRAINTS. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 3 98.92 -61.20 REMARK 500 2 ARG A 12 25.45 -63.43 REMARK 500 3 ARG A 12 25.76 -64.08 REMARK 500 4 SER A 17 31.40 -159.58 REMARK 500 5 ARG A 12 25.50 -64.51 REMARK 500 5 CYS A 20 102.50 -164.47 REMARK 500 7 THR A 3 -141.46 -174.85 REMARK 500 7 ARG A 12 22.62 -65.93 REMARK 500 7 ASN A 23 9.57 53.89 REMARK 500 7 ILE A 26 92.58 55.32 REMARK 500 8 ARG A 12 23.96 -63.61 REMARK 500 8 LEU A 29 99.85 -68.81 REMARK 500 9 SER A 17 84.37 -161.48 REMARK 500 10 ARG A 2 27.86 42.10 REMARK 500 10 THR A 3 -60.86 -147.99 REMARK 500 10 ASN A 23 3.29 56.77 REMARK 500 10 ILE A 26 88.97 54.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 15751 RELATED DB: BMRB DBREF 2K1I A 1 32 PDB 2K1I 2K1I 1 32 SEQRES 1 A 32 ARG ARG THR CYS HIS CYS ARG SER ARG CYS LEU ARG ARG SEQRES 2 A 32 GLU SER ASN SER GLY SER CYS ASN ILE ASN GLY ARG ILE SEQRES 3 A 32 PHE SER LEU CYS CYS ARG SHEET 1 A 3 CYS A 4 ARG A 7 0 SHEET 2 A 3 ARG A 25 CYS A 31 -1 O CYS A 30 N HIS A 5 SHEET 3 A 3 SER A 15 ILE A 22 -1 N CYS A 20 O PHE A 27 SSBOND 1 CYS A 4 CYS A 31 1555 1555 2.02 SSBOND 2 CYS A 6 CYS A 20 1555 1555 2.02 SSBOND 3 CYS A 10 CYS A 30 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1